Study of Flavocoxid (Limbrel) Versus Naproxen in Subjects With Moderate-Severe Osteoarthritis of the Knee

NCT00928837 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

DIETARY_SUPPLEMENT: Flavocoxid 500 mg
DRUG: Naproxen
OTHER: Placebo
OTHER: flavocoxid 250 mg

Sponsor

Primus Pharmaceuticals